Nifty

:

25461.00

Sensex

:

83432.89

55.70 (0.22%)
193.42 (0.23%)

Login

Nifty
Sensex

:
:

25461.00
83432.89

55.70 (0.22%)
193.42 (0.23%)

Jagsonpal Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :

75/99

BSE: 507789 | NSE: JAGSNPHARM

Watchlist

NSE BSE

231.08

04-Jul-2025

Open
High
Low
Previous Close

230.13
232
228.23
229.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

48320
11130662.29
328.04
130.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,539.09
27.80
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,410.36
1.08%
6.41

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

4.21
5.65
-1.38

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.21
22.02
-1.61

PAT CAGR (%)

10 Years
5 Years
3 Years

34.38
23.34
6.00

P:E (Median)

8 Years
5 Years
3 Years

22.71
34.06
39.83

P:BV (Average)

8 Years
5 Years
3 Years

4.82
5.12
6.45

EV:EBITDA (Average)

8 Years
5 Years
3 Years

279.50
21.39
27.15

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 58.56 43.49 34.65% 74.03 47.23 56.74% 74.69 57.83 29.15% 61.44 60.15 2.14%
Expenses 49.85 40.82 22.12% 58.19 43.84 32.73% 58.41 49.46 18.10% 51.20 51.52 -0.62%
EBITDA 8.71 2.67 226.22% 15.83 3.40 365.59% 16.28 8.36 94.74% 10.24 8.64 18.52%
EBIDTM 14.88% 6.14% 21.39% 7.19% 21.80% 14.47% 16.66% 14.36%
Other Income 2.77 2.49 11.24% 2.32 2.52 -7.94% 1.65 2.27 -27.31% 1.44 2.00 -28.00%
Interest 0.26 0.22 18.18% 0.26 0.23 13.04% 0.23 0.22 4.55% 0.22 0.15 46.67%
Depreciation 2.31 0.40 477.50% 2.41 0.41 487.80% 2.34 0.45 420.00% 1.07 0.39 174.36%
PBT 8.71 4.54 91.85% 38.67 5.28 632.39% 15.37 9.96 54.32% 7.11 10.09 -29.53%
Tax 2.13 0.99 115.15% 6.68 1.32 406.06% 3.91 2.49 57.03% 1.78 2.61 -31.80%
PAT 6.58 3.55 85.35% 31.99 3.96 707.83% 11.46 7.47 53.41% 5.33 7.48 -28.74%
PATM 11.24% 8.16% 43.22% 8.39% 15.34% 12.92% 8.67% 12.43%
EPS 0.99 0.53 86.79% 4.82 0.60 703.33% 1.73 1.13 53.10% 0.80 1.13 -29.20%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 268.72 208.70 236.71 217.58 187.95 158.57 166.83 126.53 143.87 143.49 138.15 Net Sales Growth 28.76% -11.83% 8.79% 15.76% 18.53% -4.95% 31.85% -12.05% 0.26% 3.87% Cost Of Goods Sold 96.91 79.98 92.34 88.96 80.78 56.19 72.85 61.11 58.95 59.13 68.68 Gross Profit 171.81 128.72 144.37 128.62 107.17 102.38 93.98 65.42 84.92 84.36 69.47 GP Margin 63.94% 61.68% 60.99% 59.11% 57.02% 64.56% 56.33% 51.70% 59.03% 58.79% 50.29% Total Expenditure 217.65 185.63 202.56 192.56 168.87 150.04 157.49 137.64 138.10 131.68 129.42 Power & Fuel Cost - 0.17 0.29 0.47 0.52 0.76 1.41 1.00 2.12 2.26 1.77 % Of Sales - 0.08% 0.12% 0.22% 0.28% 0.48% 0.85% 0.79% 1.47% 1.58% 1.28% Employee Cost - 61.80 65.18 57.67 53.98 50.37 46.61 41.88 40.95 37.84 32.11 % Of Sales - 29.61% 27.54% 26.51% 28.72% 31.77% 27.94% 33.10% 28.46% 26.37% 23.24% Manufacturing Exp. - 0.73 0.52 1.05 0.62 0.51 0.73 0.96 1.34 1.70 1.01 % Of Sales - 0.35% 0.22% 0.48% 0.33% 0.32% 0.44% 0.76% 0.93% 1.18% 0.73% General & Admin Exp. - 21.93 22.44 28.47 18.75 23.55 19.03 16.31 16.44 13.61 9.64 % Of Sales - 10.51% 9.48% 13.08% 9.98% 14.85% 11.41% 12.89% 11.43% 9.48% 6.98% Selling & Distn. Exp. - 19.16 19.21 13.88 12.99 17.45 13.20 11.25 13.74 12.96 11.53 % Of Sales - 9.18% 8.12% 6.38% 6.91% 11.00% 7.91% 8.89% 9.55% 9.03% 8.35% Miscellaneous Exp. - 1.87 2.57 2.05 1.22 1.20 3.66 5.14 4.56 4.19 11.53 % Of Sales - 0.90% 1.09% 0.94% 0.65% 0.76% 2.19% 4.06% 3.17% 2.92% 3.38% EBITDA 51.06 23.07 34.15 25.02 19.08 8.53 9.34 -11.11 5.77 11.81 8.73 EBITDA Margin 19.00% 11.05% 14.43% 11.50% 10.15% 5.38% 5.60% -8.78% 4.01% 8.23% 6.32% Other Income 8.18 9.28 5.73 3.43 4.39 2.53 1.43 0.46 0.47 0.66 0.11 Interest 0.97 0.81 0.41 0.28 0.51 0.51 0.75 0.66 2.64 5.30 4.46 Depreciation 8.13 1.66 1.21 1.53 1.09 1.13 1.02 0.32 1.99 3.09 2.71 PBT 69.86 29.87 38.27 26.64 21.87 9.41 9.00 -11.63 1.60 4.08 1.67 Tax 14.50 7.41 8.09 7.79 4.81 1.54 1.79 -0.08 2.53 0.82 0.50 Tax Rate 20.76% 24.81% 23.24% 29.24% 21.99% 16.37% 19.89% 0.69% 17.57% 20.10% 29.94% PAT 55.36 22.46 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 PAT before Minority Interest 55.36 22.46 26.72 18.86 17.06 7.87 7.22 -11.55 11.86 3.25 1.17 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.60% 10.76% 11.29% 8.67% 9.08% 4.96% 4.33% -9.13% 8.24% 2.26% 0.85% PAT Growth 146.48% -15.94% 41.68% 10.55% 116.77% 9.00% - - 264.92% 177.78% EPS 8.34 3.38 4.02 2.84 2.57 1.19 1.09 -1.74 1.79 0.49 0.18

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 187.40 158.89 132.76 121.93 111.03 104.47 98.05 109.91 98.36 95.43 Share Capital 13.22 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 13.10 Total Reserves 157.11 137.03 119.66 108.83 97.93 91.37 84.95 96.81 85.27 82.33 Non-Current Liabilities 10.55 8.48 4.49 1.88 3.09 3.12 3.19 3.26 3.61 3.60 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.92 1.07 1.26 0.02 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 27.64 35.18 34.14 40.40 34.57 28.19 28.58 29.44 57.31 55.19 Trade Payables 7.60 16.58 18.55 18.05 11.71 11.86 9.09 8.98 9.73 7.87 Other Current Liabilities 10.78 10.60 7.70 10.89 8.16 5.60 6.10 7.12 6.61 6.24 Short Term Borrowings 0.00 0.00 0.00 6.79 6.40 3.79 8.30 7.93 38.49 39.31 Short Term Provisions 9.26 8.01 7.89 4.67 8.30 6.95 5.09 5.41 2.48 1.77 Total Liabilities 225.59 202.55 171.39 164.21 148.69 135.78 129.82 142.61 159.28 154.22 Net Block 9.30 24.28 22.60 25.72 24.44 21.64 21.32 21.59 51.61 51.96 Gross Block 11.59 32.87 58.13 60.12 58.17 55.00 53.66 52.88 90.35 87.61 Accumulated Depreciation 2.29 8.59 35.53 34.40 33.74 33.36 32.34 31.28 38.74 35.65 Non Current Assets 17.82 30.39 55.14 43.73 52.39 38.23 35.20 32.50 58.32 58.43 Capital Work in Progress 0.00 0.00 0.00 0.00 1.90 3.95 3.04 0.00 0.00 0.00 Non Current Investment 0.00 1.12 28.86 12.06 11.39 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.72 0.69 1.07 5.66 14.53 12.63 10.84 10.90 6.71 6.47 Other Non Current Assets 6.81 4.29 2.62 0.29 0.13 0.00 0.00 0.00 0.00 0.00 Current Assets 190.59 172.17 116.25 120.48 96.31 97.56 94.61 110.11 100.96 95.79 Current Investments 0.00 0.00 21.81 3.25 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 15.00 20.68 29.74 29.72 29.32 32.69 51.43 47.62 39.84 33.06 Sundry Debtors 10.95 20.87 15.58 12.66 21.45 20.75 25.15 39.41 41.69 44.89 Cash & Bank 147.93 114.63 25.25 60.23 40.49 38.53 14.51 20.06 15.53 15.02 Other Current Assets 16.71 1.15 1.41 0.27 5.04 5.58 3.51 3.03 3.90 2.83 Short Term Loans & Adv. 15.35 14.85 22.47 14.34 4.52 4.64 3.27 2.80 3.90 2.83 Net Current Assets 162.95 136.99 82.11 80.08 61.74 69.37 66.03 80.68 43.65 40.60 Total Assets 208.41 202.56 171.39 164.21 148.70 135.79 129.81 142.61 159.28 154.22

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 35.17 46.66 6.91 28.22 11.89 30.90 -1.58 -3.24 9.04 4.30 PBT 29.87 34.81 26.64 21.87 9.41 9.00 -11.63 14.40 4.08 1.67 Adjustment 8.27 9.63 -1.40 -2.09 -0.57 0.33 1.26 -8.63 7.73 7.05 Changes in Working Capital 5.54 9.50 -11.46 11.59 4.84 19.71 8.79 -6.13 -1.96 -4.09 Cash after chg. in Working capital 43.68 53.93 13.79 31.37 13.69 29.05 -1.58 -0.36 9.85 4.63 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.51 -7.28 -6.87 -3.15 -1.80 1.85 0.00 -2.88 -0.82 -0.33 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -24.55 -57.67 -25.78 -2.26 -11.07 -0.83 -3.37 41.29 -2.09 -0.46 Net Fixed Assets 21.28 25.26 1.99 -0.05 -1.12 -2.25 -3.82 37.47 -2.74 1.75 Net Investments 1.12 49.55 -35.36 -3.92 -11.39 0.00 0.00 0.00 0.00 0.00 Others -46.95 -132.48 7.59 1.71 1.44 1.42 0.45 3.82 0.65 -2.21 Cash from Financing Activity -8.91 -0.46 -17.55 -6.83 -1.82 -6.05 -0.60 -33.52 -6.43 -1.42 Net Cash Inflow / Outflow 1.71 -11.47 -36.42 19.13 -1.01 24.02 -5.55 4.53 0.52 2.41 Opening Cash & Equivalents 11.05 22.53 58.94 39.81 40.82 14.51 20.06 15.53 15.02 12.60 Closing Cash & Equivalent 12.76 11.05 22.53 58.94 39.81 38.53 14.51 20.06 15.53 15.02

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 25.77 57.30 50.68 43.55 39.39 36.89 34.43 38.96 34.55 33.43 ROA 10.49% 14.29% 11.24% 10.90% 5.53% 5.43% -8.48% 7.86% 2.08% 0.75% ROE 14.02% 18.89% 15.28% 15.70% 7.88% 7.72% -12.01% 12.32% 3.65% 1.35% ROCE 17.72% 24.15% 21.23% 19.43% 9.46% 9.80% -10.52% 14.26% 7.32% 4.93% Fixed Asset Turnover 10.09 5.65 4.10 3.18 2.80 3.07 2.38 2.03 1.62 1.59 Receivable days 25.88 25.87 21.26 33.13 48.57 50.22 93.07 102.03 109.58 118.23 Inventory Days 29.02 35.78 44.76 57.34 71.38 92.03 142.78 110.02 92.27 83.52 Payable days 55.17 69.43 75.08 67.24 34.46 31.91 27.07 22.17 21.36 15.26 Cash Conversion Cycle -0.27 -7.78 -9.07 23.23 85.49 110.33 208.78 189.88 180.49 186.49 Total Debt/Equity 0.00 0.00 0.00 0.06 0.06 0.04 0.09 0.08 0.43 0.45 Interest Cover 37.69 85.28 94.48 43.59 19.31 13.08 -16.69 6.44 1.77 1.37

Top Investors:

mukul mahavir agrawal

investor education and protection fund (iepf)

authum investment and infrastructure limited

sanjiv kumar dudeja

lincoln p coelho

Annual Reports:

News Update:

Jagsonpal Pharma - Quarterly Results
6th May 2025, 18:52 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback